Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · IEX Real-Time Price · USD
84.85
+2.71 (3.30%)
At close: Jul 19, 2024, 4:00 PM
86.44
+1.59 (1.87%)
Pre-market: Jul 22, 2024, 7:30 AM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $4.03 billion as of July 22, 2024. Its market cap has increased by 25.14% in one year.
Market Cap
4.03B
Enterprise Value
3.89B
1-Year Change
25.14%
Ranking
Category
Stock Price
$84.85
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $4.03B, an increase of 2,501.69%. That is a compound annual growth rate of 45.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.03B | 7.00% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.15B |
| Integer Holdings | 4.13B |
| Immunovant | 4.08B |
| Dyne Therapeutics | 4.07B |
| ImmunityBio | 4.07B |
| Ultragenyx Pharmaceutical | 3.89B |
| Guardant Health | 3.78B |
| Waystar Holding | 3.75B |